Please login to the form below

Not currently logged in
Email:
Password:

UK appoints Greg Clark as new science minister

Cabinet reshuffle also sees George Freeman made minister for life sciences

Greg Clark UK science ministerGreg Clark has been made minister for science and universities as part of Prime Minster David Cameron's cabinet reshuffle, likely to be his last before next year's general election.  

Clark, the Conservative MP for Tunbridge Wells, replaces the widely respected David Willetts to take on responsibility for areas such as the life sciences, research and innovation.  

An MP since 2005, Clark was appointed minister for cities in July 2011 and financial secretary to the Treasury in September 2012.  

Before entering politics, he worked for the Boston Consulting Group and has also worked as head of commercial policy at the BBC.

The changes also saw George Freeman, a former life sciences adviser to Willetts, handed the role of minister for life sciences, a joint ministerial position for both the Department of Health and Department of Business, Innovation & Skills.

Plaudits for Willetts

Meanwhile, the news of Clark's replacement of David Willetts prompted many from the UK life sciences sector to pay tribute to the former science minister.

Steve Bates, CEO of UK biotech association the BIA, said: “David Willetts made his mark globally as a minister through championing the UK life sciences sector.”

Willetts truly understood “what it takes to turn the UK's fantastic science into the jobs, health and wealth the UK needs in the coming decades,” Bates added.

His comments were echoed by the likes of Prof Sir Colin Blakemore, professor of neuroscience and philosophy at the University of London, who said the scientific community owes Willetts “a huge debt”. 

“Despite the fact that he's not a scientist, he went native. His personal affection and enthusiasm for science have been crucially important in sustaining the government's commitment to science through challenging times. We all hope that his departure doesn't signal a reduction in that commitment," Blakemore said.

15th July 2014

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides market research, insights, and scientific and medical communication services to the pharmaceutical industry across the...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...

Infographics